OSE Immunotherapeutics SA (EPA:OSE)

OSE Immunotherapeutics Statistics

Total Valuation

EPA:OSE has a market cap or net worth of EUR 119.50 million. The enterprise value is 106.52 million.

Market Cap	119.50M
Enterprise Value	106.52M

Important Dates

The next estimated earnings date is Monday, December 29, 2025.

Earnings Date	Dec 29, 2025
Ex-Dividend Date	n/a

Share Statistics

EPA:OSE has 22.42 million shares outstanding. The number of shares has increased by 31.11% in one year.

Current Share Class	22.42M
Shares Outstanding	22.42M
Shares Change (YoY)	+31.11%
Shares Change (QoQ)	+3.65%
Owned by Insiders (%)	24.14%
Owned by Institutions (%)	1.97%
Float	16.21M

Valuation Ratios

The trailing PE ratio is 3.65 and the forward PE ratio is 5.89.

PE Ratio	3.65
Forward PE	5.89
PS Ratio	1.43
PB Ratio	1.87
P/TBV Ratio	1.88
P/FCF Ratio	2.47
P/OCF Ratio	2.47
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 2.38, with an EV/FCF ratio of 2.20.

EV / Earnings	2.84
EV / Sales	1.28
EV / EBITDA	2.38
EV / EBIT	2.44
EV / FCF	2.20

Financial Position

The company has a current ratio of 3.46, with a Debt / Equity ratio of 0.72.

Current Ratio	3.46
Quick Ratio	3.29
Debt / Equity	0.72
Debt / EBITDA	1.03
Debt / FCF	0.95
Interest Coverage	13.79

Financial Efficiency

Return on equity (ROE) is 86.29% and return on invested capital (ROIC) is 30.59%.

Return on Equity (ROE)	86.29%
Return on Assets (ROA)	26.54%
Return on Invested Capital (ROIC)	30.59%
Return on Capital Employed (ROCE)	42.16%
Revenue Per Employee	1.30M
Profits Per Employee	585,078
Employee Count	64
Asset Turnover	0.81
Inventory Turnover	n/a

Taxes

In the past 12 months, EPA:OSE has paid 2.39 million in taxes.

Income Tax	2.39M
Effective Tax Rate	5.99%

Stock Price Statistics

The stock price has decreased by -46.27% in the last 52 weeks. The beta is 0.61, so EPA:OSE's price volatility has been lower than the market average.

Beta (5Y)	0.61
52-Week Price Change	-46.27%
50-Day Moving Average	6.13
200-Day Moving Average	6.02
Relative Strength Index (RSI)	34.74
Average Volume (20 Days)	118,139

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, EPA:OSE had revenue of EUR 83.44 million and earned 37.45 million in profits. Earnings per share was 1.46.

Revenue	83.44M
Gross Profit	83.44M
Operating Income	43.74M
Pretax Income	39.83M
Net Income	37.45M
EBITDA	43.95M
EBIT	43.74M
Earnings Per Share (EPS)	1.46

Balance Sheet

The company has 59.12 million in cash and 46.13 million in debt, giving a net cash position of 12.99 million or 0.58 per share.

Cash & Cash Equivalents	59.12M
Total Debt	46.13M
Net Cash	12.99M
Net Cash Per Share	0.58
Equity (Book Value)	63.81M
Book Value Per Share	2.91
Working Capital	49.71M

Cash Flow

In the last 12 months, operating cash flow was 48.44 million and capital expenditures -77,000, giving a free cash flow of 48.36 million.

Operating Cash Flow	48.44M
Capital Expenditures	-77,000
Free Cash Flow	48.36M
FCF Per Share	2.16

Margins

Gross margin is 100.00%, with operating and profit margins of 52.42% and 44.88%.

Gross Margin	100.00%
Operating Margin	52.42%
Pretax Margin	47.74%
Profit Margin	44.88%
EBITDA Margin	52.67%
EBIT Margin	52.42%
FCF Margin	57.96%

Dividends & Yields

EPA:OSE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-31.11%
Shareholder Yield	-31.11%
Earnings Yield	31.33%
FCF Yield	40.47%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

EPA:OSE has an Altman Z-Score of 4.18 and a Piotroski F-Score of 6.

Altman Z-Score	4.18
Piotroski F-Score	6